Diagnostics sector poised for sustained growth through FY27, analysts say

India's diagnostics majors are positioned to sustain strong volume growth over the next two fiscal years, according to multiple brokerage assessments. The sector's expansion will be underpinned by a combination of factors including stable pricing power, increasing demand from individual consumers, and the ability of large players to leverage their operational scale for profitability gains.

Analysts tracking the listed diagnostics companies attribute the positive outlook to structural demand tailwinds. Direct-to-consumer (B2C) growth has emerged as a significant contributor, reflecting changing consumer behavior and heightened health awareness across India's urban and semi-urban centers. This shift is expected to sustain momentum even as traditional institutional channels continue to generate steady volumes.

Pricing stability in the diagnostics space provides another pillar of support for growth projections. Unlike sectors facing margin pressures, diagnostics companies have demonstrated the ability to maintain pricing discipline while expanding their service networks. This environment allows major players to invest in capacity expansion and technology upgrades without eroding profitability.

Operating leverage represents the third critical element in the growth narrative. As diagnostics companies scale their operations across India, fixed cost absorption improves, translating into better earnings growth relative to volume expansion. This dynamic is expected to persist through FY27, providing shareholders with multiplier benefits from volume growth.